Heidi Dutton

Heidi Dutton

Auto-generated profile, based on publicly available information

Heidi Dutton

Department of Medicine, University of Ottawa; Aroga Lifestyle Medicine Ottawa

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Medical Clinics of North America
Verified
Journal Article
Closed access
HDHeidi Dutton
Heidi Dutton
SBSarah Borengasser
Sarah Borengasser
LGLaura Gaudet
Laura Gaudet
LBLinda A. Barbour
Linda A. Barbour
EKErin Joanne Keely
Erin Joanne Keely

25 March 2019 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
JPJane Park
Jane Park
ALAlyssa De Luca
Alyssa De Luca
HDHeidi Dutton
Heidi Dutton
JMJanine C Malcolm
Janine C Malcolm
MDMary-Anne Doyle
Mary-Anne Doyle
There is growing evidence that Autonomous Cortisol Secretion (ACS), previously known as Subclinical Cushing’s Syndrome is associated with greater prevalence of cardiovascular (CV) risk factors. It is, however, unclear if ACS is associated with increased CV outcomes compared with non-functioning adrenal adenomas (NFAA). The objective of this study is to evaluate 1) CV outcomes and 2) CV risk factors in adrenal adenoma patients with ACS versus NFAA. A literature review was performed using EMBASE, Medline, Cochrane Library and reference lists within selected articles. The study protocol was registered with PROSPERO. A literature search yielded 6 studies that met the inclusion criteria. Studies varied on their definitions of ACS and CV outcomes. Two retrospective longitudinal studies further demonstrated increased incidence of new CV events (ACS 16.7% vs NFAA 6.7%, p=0.04), and increased CV mortality in patients with ACS (ACS 22.6% vs 2.5%, p=0.02). The prevalence of CV outcomes in ACS was > 3 times greater than in patients with NFAA. Three of five studies found that ACS was associated with higher prevalence of DM and HTN. There was no difference in dyslipidemia or BMI demonstrated in any study. There is significant heterogeneity among the few studies evaluating the association between ACS and CV outcomes. While these studies suggest an increased risk of CV outcomes in patients with ACS, many did not adjust for known confounders. Larger, high quality, prospective studies are needed to evaluate this association and to identify modifiable risk factors.

24 August 2017 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
HDHeidi Dutton
Heidi Dutton
MDMary-Anne Doyle
Mary-Anne Doyle
CBC. Arianne Buchan
C. Arianne Buchan
SMShuhiba Mohammad
Shuhiba Mohammad
KAKristi B. Adamo
Kristi B. Adamo
DFDean A. Fergusson
Dean A. Fergusson
The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to play a causative role in increasing body weight. There is evidence that antibiotics can modify the composition and diversity of the gut microbiome and that this may contribute to body weight changes. The primary objective of the proposed systematic review is to evaluate and synthesize the existing evidence evaluating the possible association between antibiotic use, weight gain, and obesity. A comprehensive search of the MEDLINE and EMBASE databases will be performed. Both randomized and non-randomized studies (excluding case reports) in neonates, children, adults, and pregnant women will be included. The exposure of interest is antibiotics of any type, duration, and route given for any indication. All included studies must have a comparator group. The primary outcomes are the development of overweight and obesity. Secondary outcomes are percent weight-change from baseline and change in body mass index or waist circumference. Additional secondary outcomes in pregnant women are gestational weight gain, postpartum weight retention, offspring birth weight, childhood weight, and obesity. Risk of bias of included trials will be performed. Two reviewers will screen and perform data extraction independently. This systematic review will summarize the existing evidence evaluating the association between antibiotic use, weight gain, and obesity and facilitate the identification of important gaps and uncertainties in the literature. PROSPERO CRD42017069177

12 October 2023 in Canadian Diabetes & Endocrinology Today
Verified
Journal Article
Open access
PDF file
HDHeidi Dutton
Heidi Dutton
A whole food plant-based (WFPB) diet is generally defined as a diet rich in fruits, vegetables, whole grains, legumes, nuts and seeds, and herbs and spices. Many define a WFPB diet as being exclusively plant-based with no animal products, excluding all red meat, poultry, fish, eggs, and dairy products. Other sources define it as a plant-forward dietary pattern that may still include small amounts of meat, eggs or dairy. A WFPB dietary pattern focuses on unprocessed plant foods, while avoiding processed foods containing refined grains, refined oils and added sugars. Figure 1 depicts an example of a balanced WFPB meal. On a practical level, it is important to distinguish a WFPB diet from a vegan diet, which eliminates all animal products but may include processed vegan foods (e.g., plant-based meats, pastries and fried foods). However, in the scientific literature, the term “vegan” is often used, and at times it is difficult to assess the amount of processed food included in diets of vegans included in observational studies. This paper will focus primarily on the evidence for an exclusively WFPB dietary pattern in the prevention and management of Type 2 diabetes mellitus (T2DM) and obesity. However, given certain limitations in the literature, some data on vegan diets and plant-rich but not exclusively plant-based diets will also be included.